Market open

Merck & Co./$MRK

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Merck & Co.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Ticker

$MRK

Trading on

NYSE

Industry

Pharmaceuticals

Employees

74,000

Merck & Co. Metrics

BasicAdvanced
$239B
14.06
$6.74
0.36
$3.12
3.42%
$239B
0.36
$134.63
$81.04
18M
$3.12
1.365
0.873
76.208
82.528
45.80%
19.58%
13.90%
41.69%
14.063
3.751
5.39
41.39
13.255
3.29%
3.42%
6.74%
4,711.66%
9.63%
9.45%
5.81%

What the Analysts think about Merck & Co.

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Merck & Co. stock.

Merck & Co. Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Merck & Co. Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MRK

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

Mar17
Merck & Co.
Dividend·Ex-dividend
Apr7
Merck & Co.
Dividend·Payment
$0.81
Per share
FAQs

What’s the current market cap for Merck & Co. stock?

Merck & Co. (MRK) has a market cap of $239B as of March 12, 2025.

What is the P/E ratio for Merck & Co. stock?

The price to earnings (P/E) ratio for Merck & Co. (MRK) stock is 14.06 as of March 12, 2025.

Does Merck & Co. stock pay dividends?

Yes, the Merck & Co. (MRK) stock pays dividends to shareholders. As of March 12, 2025, the dividend rate is $3.12 and the yield is 3.42%. Merck & Co. has a payout ratio of 45.8% on a trailing twelve-month basis.

When is the next Merck & Co. dividend payment date?

The next Merck & Co. (MRK) dividend payment is scheduled for April 07, 2025.

What is the beta indicator for Merck & Co.?

Merck & Co. (MRK) has a beta rating of 0.36. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.